Anticardiolipin antibodies in acute rheumatic fever and chronic rheumatic heart disease: Is there a significant association?

Narin N., Kutukculer N., Narin F., Keser G., Doganavsargil E.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, vol.14, no.5, pp.567-569, 1996 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 14 Issue: 5
  • Publication Date: 1996
  • Journal Name: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.567-569
  • Erciyes University Affiliated: Yes

Abstract

Objective. The incidence and significance of IgG and IgM anticardiolipin in antibodies (aCLa) in patients with acute rheumatic fever (ARF), chronic rheumatic heart disease (CRHD) and streptococcal pharyngitis have been investigated in order to determine whether these antibodies play an important role in the pathogenesis and if they are markers that can be used to confirm disease activity.